Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Grant A. McArthur
Based on 97 articles published since 2007
||||
Expertise Level
The expertise of Grant A. McArthur ranks in the
  • Top 0.024%
  • ... of 104,046 published authors worldwide on Melanoma
  • ... from 2007 through 2018
  • ... based on contributions to 97 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases McArthur, G   ·   McArthur, Grant   ·   McArthur, Grant A   ·   McArthur, G A
Work Locations
Details
Most likely:    Peter MacCallum Cancer Centre      
2018
  • Departments of Medical Oncology. · Victorian Melanoma Service, The Alfred Hospital. · Anatomical Pathology. · Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia. · Pubmed 26325493
2017
  • Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Pubmed 28789707
  • Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: · Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Department of Dermatology, Timone Hospital and Aix-Marseille University, Marseille, France. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia, The University of Sydney, and Royal North Shore Hospital, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia and University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University of Tuebingen, Tuebingen, Germany. · Pubmed 28756137
  • Cancer Medicine, The Peter MacCallum Cancer Centre, Melbourne, Australia. · The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Cancer imaging, The Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia. · The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Cancer imaging, The Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia. · Pubmed 28389693
  • Institut Universitaire du Cancer, Toulouse, France. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Oslo University Hospital, Norway. · Peter MacCallum Cancer Centre and the University of Melbourne, Australia. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · National Cancer Center Hospital, Tokyo, Japan. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology and Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Clínic, Barcelona, Spain. · Crown Princess Mary Cancer Centre Westmead Hospital, Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia. · Macquarie University, Sydney, New South Wales, Australia. · Spanish National Cancer Research Centre (CNIO) and Centro Integral Oncologico Clara Campal, Madrid, Spain. · Institut Universitaire du Cancer, Toulouse, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. · University Hospital Zurich, Zurich, Switzerland. · Pubmed 28611198
  • Department of Dermato Cancerology, Nantes University, Nantes, France. · Department of Medicine, Hematology/Oncology, Jonsson Comprehensive Cancer Center, The University of California, Los Angeles, Los Angeles, USA. · Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, Centre Hospitalier Lyon Sud, Lyon 1 University, Lyons Cancer Research Center, France. · Dermatology and Cutaneous Oncology, Aix-Marseille University Hôpital de la Timone AP-HM, Marseille, France. · Department of Clinical Development, Genentech Inc., South San Francisco, USA. · Product Development Oncology, Genentech Inc., South San Francisco, USA. · Biostatistics, Genentech Inc., South San Francisco, USA. · Medical Affairs, Genentech, Inc., South San Francisco, USA. · Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28444112
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne and University of Melbourne, Parkville, Australia. · AOU Senese Policlinico Santa Maria Alle Scotte, Siena, Italy. · Department of Medical Oncology, Hospital Clínic Barcelona, Spain. · Mount Vernon Hospital, Centre for Cancer Treatment, Northwood, UK. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · University Paris Descartes, Hospital Cochin, APHP, Paris, France. · Department of Dermatology, University Hospital Tuebingen, Tuebingen. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel. · Department of Dermatology, Comprehensive Cancer Center, University Hospital Essen, Essen, Germany. · Angeles Clinic and Research Institute, Los Angeles, USA. · Fachklinik Hornheide, Munster, Germany. · Moffitt Cancer Center, Tampa, USA. · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. · Crown Princess Cancer Centre Westmead Hospital and Department of Clinical Medicine, Macquarie University, Sydney NSW, Australia. · Seattle Cancer Care Alliance, Seattle, USA. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University of Colorado Cancer Center, Aurora. · City of Hope, Duarte, USA. · Pubmed 27993793
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medicine, Institut Gustave Roussy and Paris Sud University, Paris, France. · Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medicine, Hematology and Oncology, Jonsson Comprehensive Cancer Center at the University of California Los Angeles, Los Angeles, USA. · Division of Medical Oncology and Hematology, Princess Margaret Hospital and University Health Network, Toronto, Canada. · The Angeles Clinic and Research Institute, Melanoma Therapeutics, Los Angeles, USA. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples. · Melanoma and Sarcoma, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Oncology, University of Manchester, Manchester, UK. · Department of Dermatology, University of Zurich, Zurich, Switzerland. · Department of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Biostatistics in Product Development, Biometrics. · Clinical Department. · Product Development, Oncology, Genentech Inc., South San Francisco, USA. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Oncology, Peter MacCallum Cancer Centre, East Melbourne. · Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 28961848
  • Victorian Melanoma Service, Alfred Hospital, Melbourne, Victoria 3004, Australia. · School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria 3004, Australia. · Department of Medical Oncology, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Divisions of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3000, Australia. · Department of Anatomical Pathology, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Skin and Cancer Foundation, Carlton, Victoria 3053, Australia. · Pubmed 28787433
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Department of Palliative Care, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Cancer Experiences Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28661584
  • Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Aix-Marseille University, Hôpital de la Timone, Marseille, France. · Ospedale Monaldi, Naples, Italy. · Royal Marsden NHS Foundation Trust, London, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK. · Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Genentech, Inc., South San Francisco, CA, USA. · Nantes University, Nantes, France. · Pubmed 28646893
  • Genentech, Inc., South San Francisco, California. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, and University of Melbourne, Parkville, Victoria, Australia. · Nantes University, Nantes, France. · The Royal Marsden NHS Foundation Trust, London, United Kingdom. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · HistoGeneX, Antwerp, Belgium. · Genentech, Inc., South San Francisco, California. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, California. · Pubmed 28536307
  • Peter MacCallum Cancer Centre, East Melbourne, Australia. · Elbe-Klinikum Buxtehude, Buxtehude, Germany. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Hospital Clinic Barcelona, Barcelona, Spain. · Mapi, Stockholm, Sweden. · MSD Sharp & Dohme GmbH, Haar, Germany. · Universitäts-Hautklinik Kiel, Kiel, Germany. · Merck & Co., Inc., Kenilworth, New Jersey, USA. · Merck & Co., Inc., Kenilworth, New Jersey, USA · Pubmed 28526721
  • Medical Oncology Unit, Austin Health, Melbourne, Victoria 3084, Australia. · Olivia Newton-John Cancer Research Institute, Melbourne, Victoria 3084, Australia. · La Trobe University School of Cancer Medicine, Melbourne, Victoria 3086, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales 2145, Australia. · The University of Sydney, Sydney, New South Wales 2006, Australia. · Medical Oncology Unit, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia. · Royal North Shore and Mater Hospitals, Sydney, New South Wales 2065, Australia. · Department of Clinical Medicine, Macquarie University, New South Wales 2109, Australia. · Pubmed 28524161
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Medicine, University of Melbourne, Parkville, Victoria 3010, Australia. Electronic address: · Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Medicine, University of Melbourne, Parkville, Victoria 3010, Australia; Sir Peter MacCallum, Department of Oncology, University of Melbourne, Parkville, Victoria 3010, Australia. · Pubmed 27514721
2016
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Molecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program, East Melbourne, Australia. · Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Australia. · Research Division, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, VIC, 8006, Australia. · Pubmed 27106898
  • Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia; Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Australia; Department of Pathology, University of Melbourne, Australia; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Australia. Electronic address: · Pubmed 26924126
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia. · Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131 Napoli, Italy. Electronic address: · Pubmed 26765776
  • Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. Electronic address: · 28355 Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Dermatology Department, Timone Hospital and Aix-Marseille University, Marseille, France. · University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University Tuebingen, 72074 Tuebingen, Germany. · Pubmed 26707829
  • Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. Electronic address: · Nantes University, Nantes, France. · Princess Alexandra Hospital, Woolloongabba, QLD, Australia. · National Institute of Oncology, Budapest, Hungary. · Azienda Ospedaliera Universitaria Senese, Siena, Italy. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · N N Blokhin Russian Cancer Research Center, Moscow, Russia. · Moscow City Oncology Hospital 62, Krasnogorsk, Russia. · Centre Hospitalier Lyon Sud, Lyon 1 University, Lyon, France; Lyons Cancer Research Center, Lyon, France. · Hospital Universitario Virgen Macarena, Seville, Spain. · Hôpital Saint André, Bordeaux, France. · University of Tübingen, Tübingen, Germany. · Genentech Inc, South San Francisco, CA, USA. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, Los Angeles, CA, USA. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 27480103
  • Princess Alexandra Hospital, Greenslopes Private Hospital and University of Queensland, Brisbane, Queensland, Australia. · Melanoma Institute Australia, Royal North Shore and Mater Hospitals, The University of Sydney, Sydney, New South Wales, Australia. · Peter MacCallum Cancer Centre and Cabrini Health, Melbourne, Victoria, Australia. · Westmead Hospital, Sydney, New South Wales, Australia. · School of Medicine and Pharmacology, University of Western Australia and Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. · Queen Elizabeth Hospital, Adelaide, South Australia, Australia. · Westmead Hospital and Macquarie University, Sydney, New South Wales, Australia. · The Alfred Hospital, Melbourne, Victoria, Australia. · Olivia Newton John Cancer Wellness & Research Centre, Austin Health Melbourne, Victoria, Australia. · Pubmed 27905182
  • Monash Health, Clayton, Victoria, Australia. · Peter MacCallum Cancer Institute, Cancer Medicine, East Melbourne, Victoria, Australia. · Monash Centre for Health Research and Implementation, Melbourne, Victoria, Australia. · Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 27881588
  • Research Division, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Victoria, Australia. · Department of Pathology, University of Melbourne, Victoria, Australia. · Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Australian Capital Territory, Australia. · Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Victoria, Australia. · School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Victoria, Australia. · Pubmed 27611953
  • Children's Cancer Institute for Medical Research, Lowy Cancer Research Centre, University of New South Wales, New South Wales, Australia. · School of Women's and Children's Health, University of New South Wales Australia, New South Wales, Australia. · Priority Research Centre for Cancer Research Oncology and Immunology Unit, University of Newcastle, New South Wales, Australia. · Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia. · Centre for Drug Discovery and Development, Sansom Institute for Health Research and School of Pharmacy and Medical Sciences, University of South Australia, South Australia, Australia. · School of Chemistry, University of New South Wales Australia, New South Wales, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Victoria, Australia. · Kids Cancer Centre, Sydney Children's Hospital, New South Wales, Australia. · Pubmed 27447557
  • Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia. · School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia. · Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology and Department of Pathology, University of Melbourne, VIC, Australia. · Division of Anatomical Pathology, SA Pathology, Adelaide, SA, Australia. · Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, SA, Australia. · Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia. · Pubmed 27340778
  • Rockingham General Hospital, Cooloongup, Western Australia, Australia. · School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia. · Olivia Newton- John Cancer Centre, Austin Hospital, Heidelberg, Melbourne, Victoria, Australia. · Olivia Newton-John Cancer Research Institute, Heidelberg, Melbourne, Victoria, Australia. · The Christie NHS Foundation Trust and University of Manchester, Manchester, UK. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Princess Alexandra Hospital, Greenslopes Private Hospital, Brisbane, Queensland, Australia. · Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. · Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Box Hill Hospital, Box Hill, Victoria, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Pubmed 27124339
  • Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA. · Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, MA, USA. · Departments of Dermatology and Pathology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Developmental Therapeutics, Cancer Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Medicine and Dermatology, University of Arizona Cancer Center, Tucson, AZ, USA. · Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA. · Department of Dermatology, Knight Cancer Institute Melanoma and Skin Cancer Program, Oregon Health Science University, Portland, OR, USA. · Molecular Oncology Program, Melanoma Laboratory, CNIO, Madrid, Spain. · Department of Dermatology, Huntsman Cancer Institute, Salt Lake City, UT, USA. · Bascom Palmer Eye Institute and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. · Department of Dermatology, Stanford University Medical Center and Cancer Institute/VA Palo Alto Health Care System, Palo Alto, CA, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Department of Dermatology and Dermatopathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Dermatology, University of Zurich, Zürich, Switzerland. · Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Melanoma and Skin Cancer Program, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Pathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Medical Oncology and Dermatology, University of California Los Angeles, Los Angeles, CA, USA. · Melanoma Institute, University of Sydney, Sydney, NSW, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical School, Nashville, TN, USA. · Department of Tumor Biology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Women Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Program, Department of Dermatology, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Melanoma and Pigmented Lesion Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Dermatology, University of Bonn, Bonn, Germany. · Melanoma Research Foundation, Washington, DC, USA. · Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. · Pubmed 27087480
  • Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Victorian Melanoma Service, Alfred Hospital, Prahran, Melbourne, Vic., Australia. · Skin and Cancer Foundation, Melbourne, Vic., Australia. · Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia. · School of Cancer Medicine, La Trobe University, Olivia Newton-John Cancer Research Institute, Heidelberg, Vic., Australia. · Melbourne University, Parkville, Vic., Australia. · Pubmed 26643848
  • Peter MacCallum Cancer Centre, East Melbourne; University of Melbourne, Parkville, Victoria; Queensland Institute of Medical Research; School of Medicine, University of Queensland, Herston, Queensland, Australia. · Juntendo University School of Medicine, Tokyo, Japan. · Peter MacCallum Cancer Centre, East Melbourne; University of Melbourne, Parkville, Victoria · Pubmed 25311221
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Systems Biology & Personalized Medicine Division, Walter & Eliza Hall Institute of Medical Research (WEHI), Melbourne Department of Medicine, University of Melbourne, Melbourne, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne. · Cancer Immunology Research Laboratory, Peter MacCallum Cancer Centre, East Melbourne Department of Pathology, University of Melbourne, Parkville. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, Melbourne Department of Pathology, University of Melbourne, Parkville. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Molecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne Department of Pathology, University of Melbourne, Parkville Department of Medicine, University of Melbourne, Melbourne, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne Department of Medicine, University of Melbourne, Melbourne, Australia · Pubmed 26861600
2015
  • Department of Dermatology, University Duisburg-Essen, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Dermatology, University Tübingen, Tübingen, Germany. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Dermatology and Skin Cancers, APHM Timone Hospital Aix-Marseille University, Marseille, France. · Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania, USA. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Departments of Medicine, Surgery, and Medical and Molecular Pharmacology, University of California Los Angeles, Los Angeles, California, USA. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany. · Pubmed 27188223
  • Department of Oncology, University of Oxford, Churchill Hospital, Oxford, UK · Hematology and Medical Oncology, The Mount Sinai Medical Center, New York. · Experimental Therapeutics/Immunotherapy, The Los Angeles Clinic and Research Institute, Los Angeles. · University of California San Francisco Medical Center, University of California, San Francisco, USA. · Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK. · AbbVie Inc., North Chicago, USA. · Divisions of Cancer Medicine/Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 26202595
  • Vanderbilt-Ingram Cancer Center, Vanderbilt University, 2220 Pierce Avenue #777, Nashville, TN 37232, USA. Electronic address: · Abramson Cancer Center and the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. Electronic address: · Peter MacCallum Cancer Centre, 2 St Andrews Place, East Melbourne, Vic 3002, Australia. Electronic address: · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Vanderbilt University, 2220 Pierce Avenue #777, Nashville, TN 37232, USA. Electronic address: · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 11-934 Factor Bldg., 10833 Le Conte Ave., Los Angeles, CA 90095-1782, USA. Electronic address: · Peter MacCallum Cancer Centre, 2 St Andrews Place, East Melbourne, Vic 3002, Australia. Electronic address: · The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 11-934 Factor Bldg., 10833 Le Conte Ave., Los Angeles, CA 90095-1782, USA. Electronic address: · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. Electronic address: · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. Electronic address: · The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: · Pubmed 25980594
  • Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, NSW, Australia. · Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, NSW, Australia. · Melanoma Institute Australia, Crows Nest, Sydney, NSW, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Center for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. · School of Mathematics and Statistics, University of Sydney, NSW, Australia. · Sydney Medical School, University of Sydney, NSW, Australia. · Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Systems Biology and Cancer Metabolism, Program for Quantitative Systems Biology, University of California Merced, Merced, CA, USA. · Pubmed 26304929
  • Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Systems Biology and Personalised Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Melbourne, Victoria 3052, Australia. Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Therapeutics and Biomarkers Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. University of Sydney, Sydney, New South Wales 2006, Australia. · Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE2 7LX, UK. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia. · Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Signalling Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Pubmed 26286024
  • Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Pathology and Cell Biology, Columbia University, New York, New York. · Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia. Melanoma Institute Australia and The University of Sydney, New South Wales, Australia. · Melanoma Institute Australia and The University of Sydney, New South Wales, Australia. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · University of Texas, MD Anderson Cancer Center, Houston, Texas. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Genentech, Inc., South San Francisco, San Francisco, California. · Peter MacCallum Cancer Centre and University of Melbourne, Australia, Melbourne, Victoria, Australia. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26202952
  • Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards NSW, Australia. · Melanoma Institute of Australia, North Sydney, NSW, Australia. · Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, NSW, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · School of Mathematics and Statistics, University of Sydney, Sydney NSW, Australia. · Epinova Discovery Performance Unit, GlaxoSmithKline, Stevenage, United Kingdom. · Pubmed 26087189
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; School of Medicine, University of Queensland, Herston, QLD 4006, Australia. · Cancer Therapeutics Programs, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; School of Medicine, University of Queensland, Herston, QLD 4006, Australia. Electronic address: · Pubmed 25873170
  • Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA; Departments of Oncologic Sciences and Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA. Electronic address: · Divisions of Cancer Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, VIC, Australia. · Pubmed 25840692
  • Victorian Melanoma Service, Alfred Hospital, Melbourne, Vic., 3181, Australia. · Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., 3181, Australia. · Division of Cancer Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Vic., 3002, Australia. · Department of Oncology, St Vincent's Hospital, Fitzroy, Vic., 3065, Australia. · Translational Genomics and Epigenomics Laboratory, Ludwig Institute for Cancer Research, Olivia Newton-John Cancer and Wellness Centre, Heidelberg, Vic., 3084, Australia. · Pubmed 25752325
  • Division of Cancer Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Ludwig Institute for Cancer Research, Olivia Newton-John Cancer and Wellness Centre Heidelberg, Victoria, Australia. · School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia. · Victorian Melanoma Service, Alfred Hospital, Prahran, Victoria, Australia. · Department of Epidemiology and Preventive Medicine, Monash University, Clayton, Victoria, Australia. · Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Division of Cancer Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 25544760
2014
  • Peter MacCallum Cancer Centre, East Melbourne; University of Melbourne, Parkville, Victoria, Australia. · Pubmed 24344216
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Pathology, University of Melbourne, Grattan Street, Parkville, Victoria 3010, Australia. Electronic address: · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Pathology, University of Melbourne, Grattan Street, Parkville, Victoria 3010, Australia; Department of Medicine, St Vincent Hospital, University of Melbourne, Victoria Parade, Fitzroy, Victoria 3065, Australia. · Pubmed 24880943
  • Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · University of Colorado Comprehensive Cancer Center, Aurora, CO, USA. · New York University Medical Center, New York, NY, USA. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · University of Chicago, Chicago, IL, USA. · Hematology/Oncology Division, University of California, San Francisco, CA, USA. · Karmanos Cancer Institute, Detroit, MI, USA. · Indiana University, Indianapolis, IN, USA. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Genentech, South San Francisco, CA, USA. · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 25037139
  • Departments of Ophthalmology and the Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Genentech, South San Francisco, California. · Departments of Ophthalmology and the Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · Department of Medicine, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: · Pubmed 25036880
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. · Priority Research Centre for Cancer Research, Oncology and Immunology Unit, University of Newcastle, NSW, Australia. · Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia. · Pubmed 25333256
  • Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Pubmed 24999899
  • Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards, New South Wales, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Epinova Discovery Performance Unit, GlaxoSmithKline, Stevenage, UK. · Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards, New South Wales, Australia; Melanoma Institute of Australia, North Sydney, New South Wales, Australia. Electronic address: · Pubmed 24906137
  • Bioinformatics, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia. · Bioinformatics, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia; YourGene Biosciences Australia, Southbank, VIC, Australia. · Molecular Pathology Research and Development Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Victorian Melanoma Service, Alfred Hospital, Prahran, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Clayton, VIC, Australia; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sarcoma Genetics and Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Bioinformatics and Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia. · Molecular Pathology Research and Development Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Translational Genomics & Epigenomics Laboratory, Ludwig Institute for Cancer Research, Heidelberg, VIC, Australia. · Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Bioinformatics division, The Walter and Eliza Hall Institute for Medical Research, Parkville, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Bioinformatics and Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Medicine, St. Vincent's Hospital, Fitzroy, VIC, Australia; Department of Pathology, University of Melbourne, Parkville, VIC, Australia. · Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Pathology, University of Melbourne, Parkville, VIC, Australia. · Pubmed 24752294
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
2013
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 23248252
2012
  • Peter MacCallum Cancer Centre, Melbourne, VIC 8006, Australia. · Pubmed 22454415
2017
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.); Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; University of Colorado, Denver (R.G.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); University of Michigan, Ann Arbor (C.D.L.); the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.); Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada; Universitäts Spital, Zurich, Switzerland (R.D.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia; Netherlands Cancer Institute, Amsterdam (J.H.); University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.); General University Hospital Gregorio Marañón, Madrid (I.M.-R.); Northwestern University, Chicago (J.S.); Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.); and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
2015
  • aDepartment of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne bDepartment of Pathology, University of Melbourne, Parkville cDepartment of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy dMolecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program eTranslational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25588041
  • From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom; Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.); Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France; Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.); Department of Dermatology, University of Essen, Essen, Germany (D.S.); University of Zürich Hospital, Zurich, Switzerland (R.D.); Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie); Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia; Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.); Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.); Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York; Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.); Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc · Pubmed 26027431
2014
  • From Royal Marsden Hospital, London (J.L.); Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Azienda Ospedaliera Universitaria Senese, Siena (M. Maio), and Papa Giovanni XXIII Hospital, Bergamo (M. Mandalà) - all in Italy; Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite (L.T.), and Hôpital Saint André, Bordeaux (C.D.) - all in France; Princess Alexandra Hospital, Woolloongabba, QLD (V.A.), and Peter MacCallum Cancer Centre, Melbourne, VIC (G.A.M.) - both in Australia; National Institute of Oncology, Budapest, Hungary (G.L.); N.N. Blokhin Russian Cancer Research Center, Moscow (L.D.), and Moscow City Oncology Hospital 62, Krasnogorsk (D.S.) - both in Russia; Hospital Universitario Virgen Macarena, Seville, Spain (L.C.-M.); University of Tübingen, Tübingen, Germany (C.G.); Genentech, South San Francisco, CA (M.A.S., I.C., N.C., S.P.H.); and Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles (A.R.). · Pubmed 25265494
  • Research Division, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Pubmed 24495407
  • aDepartment of Medical Oncology, Cancer Centre, Sir Charles Gairdner Hospital bSchool of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia cPeter MacCallum Cancer Centre, East Melbourne dSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria eMelanoma Institute Australia, North Sydney fUniversity of Sydney, Sydney, New South Wales, Australia. · Pubmed 24933606
  • 1Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, 2Translational Research Laboratory, Cancer Therapeutics Program, 3Bioinformatics Core Facility, 4The Cancer Signalling Laboratory, Oncogenic Signaling and Growth Control Program, 5Gene Regulation Laboratory, Cancer Therapeutics Program, 6Molecular Imaging and Targeted Therapeutics Laboratory, Cancer Therapeutics Program, 7Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne; 8Sir Peter MacCallum Department of Oncology, Departments of 9Biochemistry and Molecular Biology, and 10Pathology, University of Melbourne, Parkville; 11Metabolic Remodelling Laboratory, Metabolic Research Unit, School of Medicine, Deakin University, Waurn Ponds; 12Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria; 13Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; 14Department of Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital; 15Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; 16Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; and 17Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California. · Pubmed 24469106
2013
  • Authors' Affiliations: Sir Peter MacCallum Department of Oncology and Departments of Pathology and Biochemistry and Molecular Biology, University of Melbourne, Parkville; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Fitzroy; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program; Translational Research Laboratory, Cancer Therapeutics Program; and Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 24089445
  • Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Pubmed 23833303
  • Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Victoria, Australia. · Pubmed 23454771
2012
  • Division of Cancer Medicine, Peter MacCallum Cancer Centre, Victoria, Australia. · Pubmed 22453013
2011
  • Melanoma and Skin Service and Head and Neck Service, Division of Surgical Oncology, Department of Surgical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia. · Pubmed 21540752
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Pubmed 21615881
2010
  • Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 20372153
  • Research Division Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia. · Pubmed 20088873
2009
  • Ludwig Institute for Cancer Research, Austin Health, Peter MacCallum Cancer Centre, CSL Limited, Melbourne, Victoria, Australia. · Pubmed 19276262
Probable:    University of Melbourne      
2017
  • Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Pubmed 28789707
  • Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: · Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Department of Dermatology, Timone Hospital and Aix-Marseille University, Marseille, France. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia, The University of Sydney, and Royal North Shore Hospital, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia and University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University of Tuebingen, Tuebingen, Germany. · Pubmed 28756137
  • Cancer Medicine, The Peter MacCallum Cancer Centre, Melbourne, Australia. · The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Cancer imaging, The Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia. · The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Cancer imaging, The Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia. · Pubmed 28389693
  • Institut Universitaire du Cancer, Toulouse, France. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Oslo University Hospital, Norway. · Peter MacCallum Cancer Centre and the University of Melbourne, Australia. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · National Cancer Center Hospital, Tokyo, Japan. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology and Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Clínic, Barcelona, Spain. · Crown Princess Mary Cancer Centre Westmead Hospital, Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia. · Macquarie University, Sydney, New South Wales, Australia. · Spanish National Cancer Research Centre (CNIO) and Centro Integral Oncologico Clara Campal, Madrid, Spain. · Institut Universitaire du Cancer, Toulouse, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. · University Hospital Zurich, Zurich, Switzerland. · Pubmed 28611198
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne and University of Melbourne, Parkville, Australia. · AOU Senese Policlinico Santa Maria Alle Scotte, Siena, Italy. · Department of Medical Oncology, Hospital Clínic Barcelona, Spain. · Mount Vernon Hospital, Centre for Cancer Treatment, Northwood, UK. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · University Paris Descartes, Hospital Cochin, APHP, Paris, France. · Department of Dermatology, University Hospital Tuebingen, Tuebingen. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel. · Department of Dermatology, Comprehensive Cancer Center, University Hospital Essen, Essen, Germany. · Angeles Clinic and Research Institute, Los Angeles, USA. · Fachklinik Hornheide, Munster, Germany. · Moffitt Cancer Center, Tampa, USA. · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. · Crown Princess Cancer Centre Westmead Hospital and Department of Clinical Medicine, Macquarie University, Sydney NSW, Australia. · Seattle Cancer Care Alliance, Seattle, USA. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University of Colorado Cancer Center, Aurora. · City of Hope, Duarte, USA. · Pubmed 27993793
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medicine, Institut Gustave Roussy and Paris Sud University, Paris, France. · Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medicine, Hematology and Oncology, Jonsson Comprehensive Cancer Center at the University of California Los Angeles, Los Angeles, USA. · Division of Medical Oncology and Hematology, Princess Margaret Hospital and University Health Network, Toronto, Canada. · The Angeles Clinic and Research Institute, Melanoma Therapeutics, Los Angeles, USA. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples. · Melanoma and Sarcoma, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Oncology, University of Manchester, Manchester, UK. · Department of Dermatology, University of Zurich, Zurich, Switzerland. · Department of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Biostatistics in Product Development, Biometrics. · Clinical Department. · Product Development, Oncology, Genentech Inc., South San Francisco, USA. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Oncology, Peter MacCallum Cancer Centre, East Melbourne. · Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 28961848
  • Victorian Melanoma Service, Alfred Hospital, Melbourne, Victoria 3004, Australia. · School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria 3004, Australia. · Department of Medical Oncology, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Divisions of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3000, Australia. · Department of Anatomical Pathology, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Skin and Cancer Foundation, Carlton, Victoria 3053, Australia. · Pubmed 28787433
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Department of Palliative Care, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Cancer Experiences Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28661584
  • Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Aix-Marseille University, Hôpital de la Timone, Marseille, France. · Ospedale Monaldi, Naples, Italy. · Royal Marsden NHS Foundation Trust, London, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK. · Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Genentech, Inc., South San Francisco, CA, USA. · Nantes University, Nantes, France. · Pubmed 28646893
  • Genentech, Inc., South San Francisco, California. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, and University of Melbourne, Parkville, Victoria, Australia. · Nantes University, Nantes, France. · The Royal Marsden NHS Foundation Trust, London, United Kingdom. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · HistoGeneX, Antwerp, Belgium. · Genentech, Inc., South San Francisco, California. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, California. · Pubmed 28536307
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Medicine, University of Melbourne, Parkville, Victoria 3010, Australia. Electronic address: · Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Medicine, University of Melbourne, Parkville, Victoria 3010, Australia; Sir Peter MacCallum, Department of Oncology, University of Melbourne, Parkville, Victoria 3010, Australia. · Pubmed 27514721
2016
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Molecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program, East Melbourne, Australia. · Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Australia. · Research Division, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, VIC, 8006, Australia. · Pubmed 27106898
  • Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia; Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Australia; Department of Pathology, University of Melbourne, Australia; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Australia. Electronic address: · Pubmed 26924126
  • Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. Electronic address: · 28355 Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Dermatology Department, Timone Hospital and Aix-Marseille University, Marseille, France. · University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University Tuebingen, 72074 Tuebingen, Germany. · Pubmed 26707829
  • Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. Electronic address: · Nantes University, Nantes, France. · Princess Alexandra Hospital, Woolloongabba, QLD, Australia. · National Institute of Oncology, Budapest, Hungary. · Azienda Ospedaliera Universitaria Senese, Siena, Italy. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · N N Blokhin Russian Cancer Research Center, Moscow, Russia. · Moscow City Oncology Hospital 62, Krasnogorsk, Russia. · Centre Hospitalier Lyon Sud, Lyon 1 University, Lyon, France; Lyons Cancer Research Center, Lyon, France. · Hospital Universitario Virgen Macarena, Seville, Spain. · Hôpital Saint André, Bordeaux, France. · University of Tübingen, Tübingen, Germany. · Genentech Inc, South San Francisco, CA, USA. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, Los Angeles, CA, USA. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 27480103
  • Monash Health, Clayton, Victoria, Australia. · Peter MacCallum Cancer Institute, Cancer Medicine, East Melbourne, Victoria, Australia. · Monash Centre for Health Research and Implementation, Melbourne, Victoria, Australia. · Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 27881588
  • Research Division, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Victoria, Australia. · Department of Pathology, University of Melbourne, Victoria, Australia. · Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Australian Capital Territory, Australia. · Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Victoria, Australia. · School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Victoria, Australia. · Pubmed 27611953
  • Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia. · School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia. · Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology and Department of Pathology, University of Melbourne, VIC, Australia. · Division of Anatomical Pathology, SA Pathology, Adelaide, SA, Australia. · Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, SA, Australia. · Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia. · Pubmed 27340778
  • Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Victorian Melanoma Service, Alfred Hospital, Prahran, Melbourne, Vic., Australia. · Skin and Cancer Foundation, Melbourne, Vic., Australia. · Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia. · School of Cancer Medicine, La Trobe University, Olivia Newton-John Cancer Research Institute, Heidelberg, Vic., Australia. · Melbourne University, Parkville, Vic., Australia. · Pubmed 26643848
  • Peter MacCallum Cancer Centre, East Melbourne; University of Melbourne, Parkville, Victoria; Queensland Institute of Medical Research; School of Medicine, University of Queensland, Herston, Queensland, Australia. · Juntendo University School of Medicine, Tokyo, Japan. · Peter MacCallum Cancer Centre, East Melbourne; University of Melbourne, Parkville, Victoria · Pubmed 25311221
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Systems Biology & Personalized Medicine Division, Walter & Eliza Hall Institute of Medical Research (WEHI), Melbourne Department of Medicine, University of Melbourne, Melbourne, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne. · Cancer Immunology Research Laboratory, Peter MacCallum Cancer Centre, East Melbourne Department of Pathology, University of Melbourne, Parkville. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, Melbourne Department of Pathology, University of Melbourne, Parkville. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Molecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne Department of Pathology, University of Melbourne, Parkville Department of Medicine, University of Melbourne, Melbourne, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne Department of Medicine, University of Melbourne, Melbourne, Australia · Pubmed 26861600
2015
  • Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Systems Biology and Personalised Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Melbourne, Victoria 3052, Australia. Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Therapeutics and Biomarkers Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. University of Sydney, Sydney, New South Wales 2006, Australia. · Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE2 7LX, UK. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia. · Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Signalling Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Pubmed 26286024
  • Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Pathology and Cell Biology, Columbia University, New York, New York. · Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia. Melanoma Institute Australia and The University of Sydney, New South Wales, Australia. · Melanoma Institute Australia and The University of Sydney, New South Wales, Australia. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · University of Texas, MD Anderson Cancer Center, Houston, Texas. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Genentech, Inc., South San Francisco, San Francisco, California. · Peter MacCallum Cancer Centre and University of Melbourne, Australia, Melbourne, Victoria, Australia. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26202952
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; School of Medicine, University of Queensland, Herston, QLD 4006, Australia. · Cancer Therapeutics Programs, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; School of Medicine, University of Queensland, Herston, QLD 4006, Australia. Electronic address: · Pubmed 25873170
  • Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA; Departments of Oncologic Sciences and Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA. Electronic address: · Divisions of Cancer Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, VIC, Australia. · Pubmed 25840692
  • Division of Cancer Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Ludwig Institute for Cancer Research, Olivia Newton-John Cancer and Wellness Centre Heidelberg, Victoria, Australia. · School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia. · Victorian Melanoma Service, Alfred Hospital, Prahran, Victoria, Australia. · Department of Epidemiology and Preventive Medicine, Monash University, Clayton, Victoria, Australia. · Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Division of Cancer Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 25544760
2014
  • Peter MacCallum Cancer Centre, East Melbourne; University of Melbourne, Parkville, Victoria, Australia. · Pubmed 24344216
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Pathology, University of Melbourne, Grattan Street, Parkville, Victoria 3010, Australia. Electronic address: · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Pathology, University of Melbourne, Grattan Street, Parkville, Victoria 3010, Australia; Department of Medicine, St Vincent Hospital, University of Melbourne, Victoria Parade, Fitzroy, Victoria 3065, Australia. · Pubmed 24880943
  • Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. · Priority Research Centre for Cancer Research, Oncology and Immunology Unit, University of Newcastle, NSW, Australia. · Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia. · Pubmed 25333256
  • Bioinformatics, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia. · Bioinformatics, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia; YourGene Biosciences Australia, Southbank, VIC, Australia. · Molecular Pathology Research and Development Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Victorian Melanoma Service, Alfred Hospital, Prahran, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Clayton, VIC, Australia; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sarcoma Genetics and Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Bioinformatics and Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia. · Molecular Pathology Research and Development Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Translational Genomics & Epigenomics Laboratory, Ludwig Institute for Cancer Research, Heidelberg, VIC, Australia. · Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Bioinformatics division, The Walter and Eliza Hall Institute for Medical Research, Parkville, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Bioinformatics and Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Medicine, St. Vincent's Hospital, Fitzroy, VIC, Australia; Department of Pathology, University of Melbourne, Parkville, VIC, Australia. · Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Pathology, University of Melbourne, Parkville, VIC, Australia. · Pubmed 24752294
2017
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.); Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; University of Colorado, Denver (R.G.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); University of Michigan, Ann Arbor (C.D.L.); the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.); Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada; Universitäts Spital, Zurich, Switzerland (R.D.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia; Netherlands Cancer Institute, Amsterdam (J.H.); University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.); General University Hospital Gregorio Marañón, Madrid (I.M.-R.); Northwestern University, Chicago (J.S.); Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.); and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
2015
  • aDepartment of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne bDepartment of Pathology, University of Melbourne, Parkville cDepartment of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy dMolecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program eTranslational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25588041
  • From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom; Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.); Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France; Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.); Department of Dermatology, University of Essen, Essen, Germany (D.S.); University of Zürich Hospital, Zurich, Switzerland (R.D.); Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie); Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia; Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.); Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.); Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York; Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.); Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc · Pubmed 26027431
2014
  • Victorian Melanoma Service, Alfred Hospital, Melbourne, Vic., Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic., Australia. · Pubmed 25043693
  • aDepartment of Medical Oncology, Cancer Centre, Sir Charles Gairdner Hospital bSchool of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia cPeter MacCallum Cancer Centre, East Melbourne dSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria eMelanoma Institute Australia, North Sydney fUniversity of Sydney, Sydney, New South Wales, Australia. · Pubmed 24933606
  • 1Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, 2Translational Research Laboratory, Cancer Therapeutics Program, 3Bioinformatics Core Facility, 4The Cancer Signalling Laboratory, Oncogenic Signaling and Growth Control Program, 5Gene Regulation Laboratory, Cancer Therapeutics Program, 6Molecular Imaging and Targeted Therapeutics Laboratory, Cancer Therapeutics Program, 7Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne; 8Sir Peter MacCallum Department of Oncology, Departments of 9Biochemistry and Molecular Biology, and 10Pathology, University of Melbourne, Parkville; 11Metabolic Remodelling Laboratory, Metabolic Research Unit, School of Medicine, Deakin University, Waurn Ponds; 12Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria; 13Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; 14Department of Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital; 15Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; 16Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; and 17Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California. · Pubmed 24469106
2013
  • Authors' Affiliations: Sir Peter MacCallum Department of Oncology and Departments of Pathology and Biochemistry and Molecular Biology, University of Melbourne, Parkville; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Fitzroy; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program; Translational Research Laboratory, Cancer Therapeutics Program; and Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 24089445
Probable:    Miscellaneous institutions in Melbourne      
2017
  • Professor of Surgery and Cancer Biology, Department of Surgical Oncology; Medical Director, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX. · Conjoint Medical Director, Melanoma Institute Australia; Clinical Professor, The University of Sydney, Sydney, New South Wales, Australia. · Senior Staff Pathologist, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Chair, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL. · Conjoint Medical Director and Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia. · Professor of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Pathology, Dermatology, and Translational Molecular Pathology; Director, Melanoma Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Co-Director, Melanoma Program; Head, Surgical Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA. · Professor of Medicine, Dermatology, and Translational Science, The University of Pittsburgh School of Medicine, Pittsburgh, PA. · Executive Director, Victorian Comprehensive Cancer Center, Melbourne, Victoria, Australia. · Manager, Clinical Data Management Systems, The University of Texas MD Anderson Cancer Center, Houston, TX. · Director General, Gustave Roussy Cancer Institute, Villejuif, France. · Director, Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center, Boston, MA. · Professor of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Melanoma and Surgical Oncology, Melanoma Institute Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 29028110
2016
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Molecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program, East Melbourne, Australia. · Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Australia. · Research Division, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, VIC, 8006, Australia. · Pubmed 27106898
2015
  • Ludwig Institute for Cancer Research (Melbourne-Austin Branch), 147-163 Studley Road, Heidelberg, VIC, 3084, Australia, · Pubmed 25662405
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 97 total) written by Grant A. McArthur about Melanoma:

  • Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics. 2018
  • Checkpoint inhibitors in melanoma and early phase development in solid tumors: what's the future? 2017
  • Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017. 2017
  • The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy. 2017
  • Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. 2017
  • Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic 2017
  • Incidence, course, and management of toxicities associated with cobimetinib in combination with vemurafenib in the coBRIM study. 2017
  • Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study. 2017
  • Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. 2017
  • Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study. 2017
Show List of Full Article Records
Google Searches

Learn more about Grant A. McArthur using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Peter MacCallum Cancer Centre
University of Melbourne
Miscellaneous institutions in Melbourne
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Peter MacCallum Cancer Centre
2018
  • Departments of Medical Oncology. · Victorian Melanoma Service, The Alfred Hospital. · Anatomical Pathology. · Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia. · Pubmed 26325493
2017
  • Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Pubmed 28789707
  • Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: · Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Department of Dermatology, Timone Hospital and Aix-Marseille University, Marseille, France. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia, The University of Sydney, and Royal North Shore Hospital, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia and University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University of Tuebingen, Tuebingen, Germany. · Pubmed 28756137
  • Cancer Medicine, The Peter MacCallum Cancer Centre, Melbourne, Australia. · The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Cancer imaging, The Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia. · The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Cancer imaging, The Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia. · Pubmed 28389693
  • Institut Universitaire du Cancer, Toulouse, France. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Oslo University Hospital, Norway. · Peter MacCallum Cancer Centre and the University of Melbourne, Australia. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · National Cancer Center Hospital, Tokyo, Japan. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology and Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Clínic, Barcelona, Spain. · Crown Princess Mary Cancer Centre Westmead Hospital, Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia. · Macquarie University, Sydney, New South Wales, Australia. · Spanish National Cancer Research Centre (CNIO) and Centro Integral Oncologico Clara Campal, Madrid, Spain. · Institut Universitaire du Cancer, Toulouse, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. · University Hospital Zurich, Zurich, Switzerland. · Pubmed 28611198
  • Department of Dermato Cancerology, Nantes University, Nantes, France. · Department of Medicine, Hematology/Oncology, Jonsson Comprehensive Cancer Center, The University of California, Los Angeles, Los Angeles, USA. · Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, Centre Hospitalier Lyon Sud, Lyon 1 University, Lyons Cancer Research Center, France. · Dermatology and Cutaneous Oncology, Aix-Marseille University Hôpital de la Timone AP-HM, Marseille, France. · Department of Clinical Development, Genentech Inc., South San Francisco, USA. · Product Development Oncology, Genentech Inc., South San Francisco, USA. · Biostatistics, Genentech Inc., South San Francisco, USA. · Medical Affairs, Genentech, Inc., South San Francisco, USA. · Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28444112
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne and University of Melbourne, Parkville, Australia. · AOU Senese Policlinico Santa Maria Alle Scotte, Siena, Italy. · Department of Medical Oncology, Hospital Clínic Barcelona, Spain. · Mount Vernon Hospital, Centre for Cancer Treatment, Northwood, UK. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · University Paris Descartes, Hospital Cochin, APHP, Paris, France. · Department of Dermatology, University Hospital Tuebingen, Tuebingen. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel. · Department of Dermatology, Comprehensive Cancer Center, University Hospital Essen, Essen, Germany. · Angeles Clinic and Research Institute, Los Angeles, USA. · Fachklinik Hornheide, Munster, Germany. · Moffitt Cancer Center, Tampa, USA. · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. · Crown Princess Cancer Centre Westmead Hospital and Department of Clinical Medicine, Macquarie University, Sydney NSW, Australia. · Seattle Cancer Care Alliance, Seattle, USA. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University of Colorado Cancer Center, Aurora. · City of Hope, Duarte, USA. · Pubmed 27993793
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medicine, Institut Gustave Roussy and Paris Sud University, Paris, France. · Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medicine, Hematology and Oncology, Jonsson Comprehensive Cancer Center at the University of California Los Angeles, Los Angeles, USA. · Division of Medical Oncology and Hematology, Princess Margaret Hospital and University Health Network, Toronto, Canada. · The Angeles Clinic and Research Institute, Melanoma Therapeutics, Los Angeles, USA. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples. · Melanoma and Sarcoma, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Oncology, University of Manchester, Manchester, UK. · Department of Dermatology, University of Zurich, Zurich, Switzerland. · Department of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Biostatistics in Product Development, Biometrics. · Clinical Department. · Product Development, Oncology, Genentech Inc., South San Francisco, USA. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Oncology, Peter MacCallum Cancer Centre, East Melbourne. · Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 28961848
  • Victorian Melanoma Service, Alfred Hospital, Melbourne, Victoria 3004, Australia. · School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria 3004, Australia. · Department of Medical Oncology, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Divisions of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3000, Australia. · Department of Anatomical Pathology, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Skin and Cancer Foundation, Carlton, Victoria 3053, Australia. · Pubmed 28787433
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Department of Palliative Care, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Cancer Experiences Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28661584
  • Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Aix-Marseille University, Hôpital de la Timone, Marseille, France. · Ospedale Monaldi, Naples, Italy. · Royal Marsden NHS Foundation Trust, London, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK. · Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Genentech, Inc., South San Francisco, CA, USA. · Nantes University, Nantes, France. · Pubmed 28646893
  • Genentech, Inc., South San Francisco, California. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, and University of Melbourne, Parkville, Victoria, Australia. · Nantes University, Nantes, France. · The Royal Marsden NHS Foundation Trust, London, United Kingdom. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · HistoGeneX, Antwerp, Belgium. · Genentech, Inc., South San Francisco, California. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, California. · Pubmed 28536307
  • Peter MacCallum Cancer Centre, East Melbourne, Australia. · Elbe-Klinikum Buxtehude, Buxtehude, Germany. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Hospital Clinic Barcelona, Barcelona, Spain. · Mapi, Stockholm, Sweden. · MSD Sharp & Dohme GmbH, Haar, Germany. · Universitäts-Hautklinik Kiel, Kiel, Germany. · Merck & Co., Inc., Kenilworth, New Jersey, USA. · Merck & Co., Inc., Kenilworth, New Jersey, USA · Pubmed 28526721
  • Medical Oncology Unit, Austin Health, Melbourne, Victoria 3084, Australia. · Olivia Newton-John Cancer Research Institute, Melbourne, Victoria 3084, Australia. · La Trobe University School of Cancer Medicine, Melbourne, Victoria 3086, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales 2145, Australia. · The University of Sydney, Sydney, New South Wales 2006, Australia. · Medical Oncology Unit, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia. · Royal North Shore and Mater Hospitals, Sydney, New South Wales 2065, Australia. · Department of Clinical Medicine, Macquarie University, New South Wales 2109, Australia. · Pubmed 28524161
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Medicine, University of Melbourne, Parkville, Victoria 3010, Australia. Electronic address: · Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Medicine, University of Melbourne, Parkville, Victoria 3010, Australia; Sir Peter MacCallum, Department of Oncology, University of Melbourne, Parkville, Victoria 3010, Australia. · Pubmed 27514721
2016
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Molecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program, East Melbourne, Australia. · Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Australia. · Research Division, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, VIC, 8006, Australia. · Pubmed 27106898
  • Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia; Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Australia; Department of Pathology, University of Melbourne, Australia; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Australia. Electronic address: · Pubmed 26924126
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia. · Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131 Napoli, Italy. Electronic address: · Pubmed 26765776
  • Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. Electronic address: · 28355 Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Dermatology Department, Timone Hospital and Aix-Marseille University, Marseille, France. · University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University Tuebingen, 72074 Tuebingen, Germany. · Pubmed 26707829
  • Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. Electronic address: · Nantes University, Nantes, France. · Princess Alexandra Hospital, Woolloongabba, QLD, Australia. · National Institute of Oncology, Budapest, Hungary. · Azienda Ospedaliera Universitaria Senese, Siena, Italy. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · N N Blokhin Russian Cancer Research Center, Moscow, Russia. · Moscow City Oncology Hospital 62, Krasnogorsk, Russia. · Centre Hospitalier Lyon Sud, Lyon 1 University, Lyon, France; Lyons Cancer Research Center, Lyon, France. · Hospital Universitario Virgen Macarena, Seville, Spain. · Hôpital Saint André, Bordeaux, France. · University of Tübingen, Tübingen, Germany. · Genentech Inc, South San Francisco, CA, USA. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, Los Angeles, CA, USA. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 27480103
  • Princess Alexandra Hospital, Greenslopes Private Hospital and University of Queensland, Brisbane, Queensland, Australia. · Melanoma Institute Australia, Royal North Shore and Mater Hospitals, The University of Sydney, Sydney, New South Wales, Australia. · Peter MacCallum Cancer Centre and Cabrini Health, Melbourne, Victoria, Australia. · Westmead Hospital, Sydney, New South Wales, Australia. · School of Medicine and Pharmacology, University of Western Australia and Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. · Queen Elizabeth Hospital, Adelaide, South Australia, Australia. · Westmead Hospital and Macquarie University, Sydney, New South Wales, Australia. · The Alfred Hospital, Melbourne, Victoria, Australia. · Olivia Newton John Cancer Wellness & Research Centre, Austin Health Melbourne, Victoria, Australia. · Pubmed 27905182
  • Monash Health, Clayton, Victoria, Australia. · Peter MacCallum Cancer Institute, Cancer Medicine, East Melbourne, Victoria, Australia. · Monash Centre for Health Research and Implementation, Melbourne, Victoria, Australia. · Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 27881588
  • Research Division, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Victoria, Australia. · Department of Pathology, University of Melbourne, Victoria, Australia. · Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Australian Capital Territory, Australia. · Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Victoria, Australia. · School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Victoria, Australia. · Pubmed 27611953
  • Children's Cancer Institute for Medical Research, Lowy Cancer Research Centre, University of New South Wales, New South Wales, Australia. · School of Women's and Children's Health, University of New South Wales Australia, New South Wales, Australia. · Priority Research Centre for Cancer Research Oncology and Immunology Unit, University of Newcastle, New South Wales, Australia. · Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia. · Centre for Drug Discovery and Development, Sansom Institute for Health Research and School of Pharmacy and Medical Sciences, University of South Australia, South Australia, Australia. · School of Chemistry, University of New South Wales Australia, New South Wales, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Victoria, Australia. · Kids Cancer Centre, Sydney Children's Hospital, New South Wales, Australia. · Pubmed 27447557
  • Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia. · School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia. · Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology and Department of Pathology, University of Melbourne, VIC, Australia. · Division of Anatomical Pathology, SA Pathology, Adelaide, SA, Australia. · Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, SA, Australia. · Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia. · Pubmed 27340778
  • Rockingham General Hospital, Cooloongup, Western Australia, Australia. · School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia. · Olivia Newton- John Cancer Centre, Austin Hospital, Heidelberg, Melbourne, Victoria, Australia. · Olivia Newton-John Cancer Research Institute, Heidelberg, Melbourne, Victoria, Australia. · The Christie NHS Foundation Trust and University of Manchester, Manchester, UK. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Princess Alexandra Hospital, Greenslopes Private Hospital, Brisbane, Queensland, Australia. · Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. · Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Box Hill Hospital, Box Hill, Victoria, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Pubmed 27124339
  • Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA. · Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, MA, USA. · Departments of Dermatology and Pathology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Developmental Therapeutics, Cancer Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Medicine and Dermatology, University of Arizona Cancer Center, Tucson, AZ, USA. · Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA. · Department of Dermatology, Knight Cancer Institute Melanoma and Skin Cancer Program, Oregon Health Science University, Portland, OR, USA. · Molecular Oncology Program, Melanoma Laboratory, CNIO, Madrid, Spain. · Department of Dermatology, Huntsman Cancer Institute, Salt Lake City, UT, USA. · Bascom Palmer Eye Institute and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. · Department of Dermatology, Stanford University Medical Center and Cancer Institute/VA Palo Alto Health Care System, Palo Alto, CA, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Department of Dermatology and Dermatopathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Dermatology, University of Zurich, Zürich, Switzerland. · Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Melanoma and Skin Cancer Program, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Pathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Medical Oncology and Dermatology, University of California Los Angeles, Los Angeles, CA, USA. · Melanoma Institute, University of Sydney, Sydney, NSW, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical School, Nashville, TN, USA. · Department of Tumor Biology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Women Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Program, Department of Dermatology, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Melanoma and Pigmented Lesion Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Dermatology, University of Bonn, Bonn, Germany. · Melanoma Research Foundation, Washington, DC, USA. · Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. · Pubmed 27087480
  • Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Victorian Melanoma Service, Alfred Hospital, Prahran, Melbourne, Vic., Australia. · Skin and Cancer Foundation, Melbourne, Vic., Australia. · Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia. · School of Cancer Medicine, La Trobe University, Olivia Newton-John Cancer Research Institute, Heidelberg, Vic., Australia. · Melbourne University, Parkville, Vic., Australia. · Pubmed 26643848
  • Peter MacCallum Cancer Centre, East Melbourne; University of Melbourne, Parkville, Victoria; Queensland Institute of Medical Research; School of Medicine, University of Queensland, Herston, Queensland, Australia. · Juntendo University School of Medicine, Tokyo, Japan. · Peter MacCallum Cancer Centre, East Melbourne; University of Melbourne, Parkville, Victoria · Pubmed 25311221
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Systems Biology & Personalized Medicine Division, Walter & Eliza Hall Institute of Medical Research (WEHI), Melbourne Department of Medicine, University of Melbourne, Melbourne, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne. · Cancer Immunology Research Laboratory, Peter MacCallum Cancer Centre, East Melbourne Department of Pathology, University of Melbourne, Parkville. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, Melbourne Department of Pathology, University of Melbourne, Parkville. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Molecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne Department of Pathology, University of Melbourne, Parkville Department of Medicine, University of Melbourne, Melbourne, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne Department of Medicine, University of Melbourne, Melbourne, Australia · Pubmed 26861600
2015
  • Department of Dermatology, University Duisburg-Essen, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Dermatology, University Tübingen, Tübingen, Germany. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Dermatology and Skin Cancers, APHM Timone Hospital Aix-Marseille University, Marseille, France. · Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania, USA. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Departments of Medicine, Surgery, and Medical and Molecular Pharmacology, University of California Los Angeles, Los Angeles, California, USA. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany. · Pubmed 27188223
  • Department of Oncology, University of Oxford, Churchill Hospital, Oxford, UK · Hematology and Medical Oncology, The Mount Sinai Medical Center, New York. · Experimental Therapeutics/Immunotherapy, The Los Angeles Clinic and Research Institute, Los Angeles. · University of California San Francisco Medical Center, University of California, San Francisco, USA. · Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK. · AbbVie Inc., North Chicago, USA. · Divisions of Cancer Medicine/Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 26202595
  • Vanderbilt-Ingram Cancer Center, Vanderbilt University, 2220 Pierce Avenue #777, Nashville, TN 37232, USA. Electronic address: · Abramson Cancer Center and the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. Electronic address: · Peter MacCallum Cancer Centre, 2 St Andrews Place, East Melbourne, Vic 3002, Australia. Electronic address: · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Vanderbilt University, 2220 Pierce Avenue #777, Nashville, TN 37232, USA. Electronic address: · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 11-934 Factor Bldg., 10833 Le Conte Ave., Los Angeles, CA 90095-1782, USA. Electronic address: · Peter MacCallum Cancer Centre, 2 St Andrews Place, East Melbourne, Vic 3002, Australia. Electronic address: · The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 11-934 Factor Bldg., 10833 Le Conte Ave., Los Angeles, CA 90095-1782, USA. Electronic address: · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. Electronic address: · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. Electronic address: · The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: · Pubmed 25980594
  • Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, NSW, Australia. · Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, NSW, Australia. · Melanoma Institute Australia, Crows Nest, Sydney, NSW, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Center for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. · School of Mathematics and Statistics, University of Sydney, NSW, Australia. · Sydney Medical School, University of Sydney, NSW, Australia. · Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Systems Biology and Cancer Metabolism, Program for Quantitative Systems Biology, University of California Merced, Merced, CA, USA. · Pubmed 26304929
  • Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Systems Biology and Personalised Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Melbourne, Victoria 3052, Australia. Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Therapeutics and Biomarkers Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. University of Sydney, Sydney, New South Wales 2006, Australia. · Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE2 7LX, UK. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia. · Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Signalling Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Pubmed 26286024
  • Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Pathology and Cell Biology, Columbia University, New York, New York. · Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia. Melanoma Institute Australia and The University of Sydney, New South Wales, Australia. · Melanoma Institute Australia and The University of Sydney, New South Wales, Australia. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · University of Texas, MD Anderson Cancer Center, Houston, Texas. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Genentech, Inc., South San Francisco, San Francisco, California. · Peter MacCallum Cancer Centre and University of Melbourne, Australia, Melbourne, Victoria, Australia. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26202952
  • Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards NSW, Australia. · Melanoma Institute of Australia, North Sydney, NSW, Australia. · Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, NSW, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · School of Mathematics and Statistics, University of Sydney, Sydney NSW, Australia. · Epinova Discovery Performance Unit, GlaxoSmithKline, Stevenage, United Kingdom. · Pubmed 26087189
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; School of Medicine, University of Queensland, Herston, QLD 4006, Australia. · Cancer Therapeutics Programs, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; School of Medicine, University of Queensland, Herston, QLD 4006, Australia. Electronic address: · Pubmed 25873170
  • Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA; Departments of Oncologic Sciences and Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA. Electronic address: · Divisions of Cancer Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, VIC, Australia. · Pubmed 25840692
  • Victorian Melanoma Service, Alfred Hospital, Melbourne, Vic., 3181, Australia. · Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., 3181, Australia. · Division of Cancer Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Vic., 3002, Australia. · Department of Oncology, St Vincent's Hospital, Fitzroy, Vic., 3065, Australia. · Translational Genomics and Epigenomics Laboratory, Ludwig Institute for Cancer Research, Olivia Newton-John Cancer and Wellness Centre, Heidelberg, Vic., 3084, Australia. · Pubmed 25752325
  • Division of Cancer Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Ludwig Institute for Cancer Research, Olivia Newton-John Cancer and Wellness Centre Heidelberg, Victoria, Australia. · School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia. · Victorian Melanoma Service, Alfred Hospital, Prahran, Victoria, Australia. · Department of Epidemiology and Preventive Medicine, Monash University, Clayton, Victoria, Australia. · Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Division of Cancer Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 25544760
2014
  • Peter MacCallum Cancer Centre, East Melbourne; University of Melbourne, Parkville, Victoria, Australia. · Pubmed 24344216
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Pathology, University of Melbourne, Grattan Street, Parkville, Victoria 3010, Australia. Electronic address: · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Pathology, University of Melbourne, Grattan Street, Parkville, Victoria 3010, Australia; Department of Medicine, St Vincent Hospital, University of Melbourne, Victoria Parade, Fitzroy, Victoria 3065, Australia. · Pubmed 24880943
  • Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · University of Colorado Comprehensive Cancer Center, Aurora, CO, USA. · New York University Medical Center, New York, NY, USA. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · University of Chicago, Chicago, IL, USA. · Hematology/Oncology Division, University of California, San Francisco, CA, USA. · Karmanos Cancer Institute, Detroit, MI, USA. · Indiana University, Indianapolis, IN, USA. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Genentech, South San Francisco, CA, USA. · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 25037139
  • Departments of Ophthalmology and the Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Genentech, South San Francisco, California. · Departments of Ophthalmology and the Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · Department of Medicine, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: · Pubmed 25036880
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. · Priority Research Centre for Cancer Research, Oncology and Immunology Unit, University of Newcastle, NSW, Australia. · Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia. · Pubmed 25333256
  • Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Pubmed 24999899
  • Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards, New South Wales, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Epinova Discovery Performance Unit, GlaxoSmithKline, Stevenage, UK. · Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards, New South Wales, Australia; Melanoma Institute of Australia, North Sydney, New South Wales, Australia. Electronic address: · Pubmed 24906137
  • Bioinformatics, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia. · Bioinformatics, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia; YourGene Biosciences Australia, Southbank, VIC, Australia. · Molecular Pathology Research and Development Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Victorian Melanoma Service, Alfred Hospital, Prahran, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Clayton, VIC, Australia; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sarcoma Genetics and Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Bioinformatics and Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia. · Molecular Pathology Research and Development Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Translational Genomics & Epigenomics Laboratory, Ludwig Institute for Cancer Research, Heidelberg, VIC, Australia. · Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Bioinformatics division, The Walter and Eliza Hall Institute for Medical Research, Parkville, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Bioinformatics and Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Medicine, St. Vincent's Hospital, Fitzroy, VIC, Australia; Department of Pathology, University of Melbourne, Parkville, VIC, Australia. · Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Pathology, University of Melbourne, Parkville, VIC, Australia. · Pubmed 24752294
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
2013
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 23248252
2012
  • Peter MacCallum Cancer Centre, Melbourne, VIC 8006, Australia. · Pubmed 22454415
2017
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.); Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; University of Colorado, Denver (R.G.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); University of Michigan, Ann Arbor (C.D.L.); the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.); Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada; Universitäts Spital, Zurich, Switzerland (R.D.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia; Netherlands Cancer Institute, Amsterdam (J.H.); University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.); General University Hospital Gregorio Marañón, Madrid (I.M.-R.); Northwestern University, Chicago (J.S.); Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.); and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
2015
  • aDepartment of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne bDepartment of Pathology, University of Melbourne, Parkville cDepartment of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy dMolecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program eTranslational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25588041
  • From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom; Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.); Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France; Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.); Department of Dermatology, University of Essen, Essen, Germany (D.S.); University of Zürich Hospital, Zurich, Switzerland (R.D.); Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie); Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia; Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.); Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.); Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York; Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.); Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc · Pubmed 26027431
2014
  • From Royal Marsden Hospital, London (J.L.); Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Azienda Ospedaliera Universitaria Senese, Siena (M. Maio), and Papa Giovanni XXIII Hospital, Bergamo (M. Mandalà) - all in Italy; Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite (L.T.), and Hôpital Saint André, Bordeaux (C.D.) - all in France; Princess Alexandra Hospital, Woolloongabba, QLD (V.A.), and Peter MacCallum Cancer Centre, Melbourne, VIC (G.A.M.) - both in Australia; National Institute of Oncology, Budapest, Hungary (G.L.); N.N. Blokhin Russian Cancer Research Center, Moscow (L.D.), and Moscow City Oncology Hospital 62, Krasnogorsk (D.S.) - both in Russia; Hospital Universitario Virgen Macarena, Seville, Spain (L.C.-M.); University of Tübingen, Tübingen, Germany (C.G.); Genentech, South San Francisco, CA (M.A.S., I.C., N.C., S.P.H.); and Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles (A.R.). · Pubmed 25265494
  • Research Division, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Pubmed 24495407
  • aDepartment of Medical Oncology, Cancer Centre, Sir Charles Gairdner Hospital bSchool of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia cPeter MacCallum Cancer Centre, East Melbourne dSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria eMelanoma Institute Australia, North Sydney fUniversity of Sydney, Sydney, New South Wales, Australia. · Pubmed 24933606
  • 1Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, 2Translational Research Laboratory, Cancer Therapeutics Program, 3Bioinformatics Core Facility, 4The Cancer Signalling Laboratory, Oncogenic Signaling and Growth Control Program, 5Gene Regulation Laboratory, Cancer Therapeutics Program, 6Molecular Imaging and Targeted Therapeutics Laboratory, Cancer Therapeutics Program, 7Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne; 8Sir Peter MacCallum Department of Oncology, Departments of 9Biochemistry and Molecular Biology, and 10Pathology, University of Melbourne, Parkville; 11Metabolic Remodelling Laboratory, Metabolic Research Unit, School of Medicine, Deakin University, Waurn Ponds; 12Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria; 13Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; 14Department of Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital; 15Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; 16Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; and 17Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California. · Pubmed 24469106
2013
  • Authors' Affiliations: Sir Peter MacCallum Department of Oncology and Departments of Pathology and Biochemistry and Molecular Biology, University of Melbourne, Parkville; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Fitzroy; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program; Translational Research Laboratory, Cancer Therapeutics Program; and Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 24089445
  • Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Pubmed 23833303
  • Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Victoria, Australia. · Pubmed 23454771
2012
  • Division of Cancer Medicine, Peter MacCallum Cancer Centre, Victoria, Australia. · Pubmed 22453013
2011
  • Melanoma and Skin Service and Head and Neck Service, Division of Surgical Oncology, Department of Surgical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia. · Pubmed 21540752
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Pubmed 21615881
2010
  • Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 20372153
  • Research Division Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia. · Pubmed 20088873
2009
  • Ludwig Institute for Cancer Research, Austin Health, Peter MacCallum Cancer Centre, CSL Limited, Melbourne, Victoria, Australia. · Pubmed 19276262
University of Melbourne
2017
  • Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Pubmed 28789707
  • Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: · Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Department of Dermatology, Timone Hospital and Aix-Marseille University, Marseille, France. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia, The University of Sydney, and Royal North Shore Hospital, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia and University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University of Tuebingen, Tuebingen, Germany. · Pubmed 28756137
  • Cancer Medicine, The Peter MacCallum Cancer Centre, Melbourne, Australia. · The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Cancer imaging, The Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia. · The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Cancer imaging, The Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia. · Pubmed 28389693
  • Institut Universitaire du Cancer, Toulouse, France. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Oslo University Hospital, Norway. · Peter MacCallum Cancer Centre and the University of Melbourne, Australia. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · National Cancer Center Hospital, Tokyo, Japan. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology and Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Clínic, Barcelona, Spain. · Crown Princess Mary Cancer Centre Westmead Hospital, Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia. · Macquarie University, Sydney, New South Wales, Australia. · Spanish National Cancer Research Centre (CNIO) and Centro Integral Oncologico Clara Campal, Madrid, Spain. · Institut Universitaire du Cancer, Toulouse, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. · University Hospital Zurich, Zurich, Switzerland. · Pubmed 28611198
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne and University of Melbourne, Parkville, Australia. · AOU Senese Policlinico Santa Maria Alle Scotte, Siena, Italy. · Department of Medical Oncology, Hospital Clínic Barcelona, Spain. · Mount Vernon Hospital, Centre for Cancer Treatment, Northwood, UK. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · University Paris Descartes, Hospital Cochin, APHP, Paris, France. · Department of Dermatology, University Hospital Tuebingen, Tuebingen. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel. · Department of Dermatology, Comprehensive Cancer Center, University Hospital Essen, Essen, Germany. · Angeles Clinic and Research Institute, Los Angeles, USA. · Fachklinik Hornheide, Munster, Germany. · Moffitt Cancer Center, Tampa, USA. · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. · Crown Princess Cancer Centre Westmead Hospital and Department of Clinical Medicine, Macquarie University, Sydney NSW, Australia. · Seattle Cancer Care Alliance, Seattle, USA. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University of Colorado Cancer Center, Aurora. · City of Hope, Duarte, USA. · Pubmed 27993793
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medicine, Institut Gustave Roussy and Paris Sud University, Paris, France. · Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medicine, Hematology and Oncology, Jonsson Comprehensive Cancer Center at the University of California Los Angeles, Los Angeles, USA. · Division of Medical Oncology and Hematology, Princess Margaret Hospital and University Health Network, Toronto, Canada. · The Angeles Clinic and Research Institute, Melanoma Therapeutics, Los Angeles, USA. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples. · Melanoma and Sarcoma, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Oncology, University of Manchester, Manchester, UK. · Department of Dermatology, University of Zurich, Zurich, Switzerland. · Department of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Biostatistics in Product Development, Biometrics. · Clinical Department. · Product Development, Oncology, Genentech Inc., South San Francisco, USA. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Oncology, Peter MacCallum Cancer Centre, East Melbourne. · Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 28961848
  • Victorian Melanoma Service, Alfred Hospital, Melbourne, Victoria 3004, Australia. · School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria 3004, Australia. · Department of Medical Oncology, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Divisions of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3000, Australia. · Department of Anatomical Pathology, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Skin and Cancer Foundation, Carlton, Victoria 3053, Australia. · Pubmed 28787433
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Department of Palliative Care, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Cancer Experiences Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28661584
  • Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Aix-Marseille University, Hôpital de la Timone, Marseille, France. · Ospedale Monaldi, Naples, Italy. · Royal Marsden NHS Foundation Trust, London, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK. · Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Genentech, Inc., South San Francisco, CA, USA. · Nantes University, Nantes, France. · Pubmed 28646893
  • Genentech, Inc., South San Francisco, California. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, and University of Melbourne, Parkville, Victoria, Australia. · Nantes University, Nantes, France. · The Royal Marsden NHS Foundation Trust, London, United Kingdom. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · HistoGeneX, Antwerp, Belgium. · Genentech, Inc., South San Francisco, California. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, California. · Pubmed 28536307
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Medicine, University of Melbourne, Parkville, Victoria 3010, Australia. Electronic address: · Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Medicine, University of Melbourne, Parkville, Victoria 3010, Australia; Sir Peter MacCallum, Department of Oncology, University of Melbourne, Parkville, Victoria 3010, Australia. · Pubmed 27514721
2016
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Molecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program, East Melbourne, Australia. · Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Australia. · Research Division, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, VIC, 8006, Australia. · Pubmed 27106898
  • Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia; Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Australia; Department of Pathology, University of Melbourne, Australia; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Australia. Electronic address: · Pubmed 26924126
  • Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. Electronic address: · 28355 Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Dermatology Department, Timone Hospital and Aix-Marseille University, Marseille, France. · University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University Tuebingen, 72074 Tuebingen, Germany. · Pubmed 26707829
  • Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. Electronic address: · Nantes University, Nantes, France. · Princess Alexandra Hospital, Woolloongabba, QLD, Australia. · National Institute of Oncology, Budapest, Hungary. · Azienda Ospedaliera Universitaria Senese, Siena, Italy. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · N N Blokhin Russian Cancer Research Center, Moscow, Russia. · Moscow City Oncology Hospital 62, Krasnogorsk, Russia. · Centre Hospitalier Lyon Sud, Lyon 1 University, Lyon, France; Lyons Cancer Research Center, Lyon, France. · Hospital Universitario Virgen Macarena, Seville, Spain. · Hôpital Saint André, Bordeaux, France. · University of Tübingen, Tübingen, Germany. · Genentech Inc, South San Francisco, CA, USA. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, Los Angeles, CA, USA. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 27480103
  • Monash Health, Clayton, Victoria, Australia. · Peter MacCallum Cancer Institute, Cancer Medicine, East Melbourne, Victoria, Australia. · Monash Centre for Health Research and Implementation, Melbourne, Victoria, Australia. · Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 27881588
  • Research Division, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Victoria, Australia. · Department of Pathology, University of Melbourne, Victoria, Australia. · Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Australian Capital Territory, Australia. · Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Victoria, Australia. · School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Victoria, Australia. · Pubmed 27611953
  • Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia. · School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia. · Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology and Department of Pathology, University of Melbourne, VIC, Australia. · Division of Anatomical Pathology, SA Pathology, Adelaide, SA, Australia. · Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, SA, Australia. · Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia. · Pubmed 27340778
  • Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Victorian Melanoma Service, Alfred Hospital, Prahran, Melbourne, Vic., Australia. · Skin and Cancer Foundation, Melbourne, Vic., Australia. · Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia. · School of Cancer Medicine, La Trobe University, Olivia Newton-John Cancer Research Institute, Heidelberg, Vic., Australia. · Melbourne University, Parkville, Vic., Australia. · Pubmed 26643848
  • Peter MacCallum Cancer Centre, East Melbourne; University of Melbourne, Parkville, Victoria; Queensland Institute of Medical Research; School of Medicine, University of Queensland, Herston, Queensland, Australia. · Juntendo University School of Medicine, Tokyo, Japan. · Peter MacCallum Cancer Centre, East Melbourne; University of Melbourne, Parkville, Victoria · Pubmed 25311221
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Systems Biology & Personalized Medicine Division, Walter & Eliza Hall Institute of Medical Research (WEHI), Melbourne Department of Medicine, University of Melbourne, Melbourne, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne. · Cancer Immunology Research Laboratory, Peter MacCallum Cancer Centre, East Melbourne Department of Pathology, University of Melbourne, Parkville. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, Melbourne Department of Pathology, University of Melbourne, Parkville. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Molecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne Department of Pathology, University of Melbourne, Parkville Department of Medicine, University of Melbourne, Melbourne, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne Department of Medicine, University of Melbourne, Melbourne, Australia · Pubmed 26861600
2015
  • Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Systems Biology and Personalised Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Melbourne, Victoria 3052, Australia. Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Therapeutics and Biomarkers Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. University of Sydney, Sydney, New South Wales 2006, Australia. · Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE2 7LX, UK. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia. · Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Signalling Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. · Pubmed 26286024
  • Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Pathology and Cell Biology, Columbia University, New York, New York. · Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia. Melanoma Institute Australia and The University of Sydney, New South Wales, Australia. · Melanoma Institute Australia and The University of Sydney, New South Wales, Australia. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · University of Texas, MD Anderson Cancer Center, Houston, Texas. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Genentech, Inc., South San Francisco, San Francisco, California. · Peter MacCallum Cancer Centre and University of Melbourne, Australia, Melbourne, Victoria, Australia. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26202952
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; School of Medicine, University of Queensland, Herston, QLD 4006, Australia. · Cancer Therapeutics Programs, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; School of Medicine, University of Queensland, Herston, QLD 4006, Australia. Electronic address: · Pubmed 25873170
  • Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA; Departments of Oncologic Sciences and Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA. Electronic address: · Divisions of Cancer Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, VIC, Australia. · Pubmed 25840692
  • Division of Cancer Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Ludwig Institute for Cancer Research, Olivia Newton-John Cancer and Wellness Centre Heidelberg, Victoria, Australia. · School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia. · Victorian Melanoma Service, Alfred Hospital, Prahran, Victoria, Australia. · Department of Epidemiology and Preventive Medicine, Monash University, Clayton, Victoria, Australia. · Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Division of Cancer Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 25544760
2014
  • Peter MacCallum Cancer Centre, East Melbourne; University of Melbourne, Parkville, Victoria, Australia. · Pubmed 24344216
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Pathology, University of Melbourne, Grattan Street, Parkville, Victoria 3010, Australia. Electronic address: · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia; Department of Pathology, University of Melbourne, Grattan Street, Parkville, Victoria 3010, Australia; Department of Medicine, St Vincent Hospital, University of Melbourne, Victoria Parade, Fitzroy, Victoria 3065, Australia. · Pubmed 24880943
  • Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. · Priority Research Centre for Cancer Research, Oncology and Immunology Unit, University of Newcastle, NSW, Australia. · Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia. · Pubmed 25333256
  • Bioinformatics, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia. · Bioinformatics, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia; YourGene Biosciences Australia, Southbank, VIC, Australia. · Molecular Pathology Research and Development Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Victorian Melanoma Service, Alfred Hospital, Prahran, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Clayton, VIC, Australia; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sarcoma Genetics and Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Bioinformatics and Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia. · Molecular Pathology Research and Development Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Translational Genomics & Epigenomics Laboratory, Ludwig Institute for Cancer Research, Heidelberg, VIC, Australia. · Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Bioinformatics division, The Walter and Eliza Hall Institute for Medical Research, Parkville, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Bioinformatics and Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Medicine, St. Vincent's Hospital, Fitzroy, VIC, Australia; Department of Pathology, University of Melbourne, Parkville, VIC, Australia. · Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Pathology, University of Melbourne, Parkville, VIC, Australia. · Pubmed 24752294
2017
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.); Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; University of Colorado, Denver (R.G.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); University of Michigan, Ann Arbor (C.D.L.); the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.); Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada; Universitäts Spital, Zurich, Switzerland (R.D.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia; Netherlands Cancer Institute, Amsterdam (J.H.); University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.); General University Hospital Gregorio Marañón, Madrid (I.M.-R.); Northwestern University, Chicago (J.S.); Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.); and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
2015
  • aDepartment of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne bDepartment of Pathology, University of Melbourne, Parkville cDepartment of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy dMolecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program eTranslational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25588041
  • From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom; Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.); Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France; Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.); Department of Dermatology, University of Essen, Essen, Germany (D.S.); University of Zürich Hospital, Zurich, Switzerland (R.D.); Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie); Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia; Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.); Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.); Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York; Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.); Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc · Pubmed 26027431
2014
  • Victorian Melanoma Service, Alfred Hospital, Melbourne, Vic., Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic., Australia. · Pubmed 25043693
  • aDepartment of Medical Oncology, Cancer Centre, Sir Charles Gairdner Hospital bSchool of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia cPeter MacCallum Cancer Centre, East Melbourne dSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria eMelanoma Institute Australia, North Sydney fUniversity of Sydney, Sydney, New South Wales, Australia. · Pubmed 24933606
  • 1Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, 2Translational Research Laboratory, Cancer Therapeutics Program, 3Bioinformatics Core Facility, 4The Cancer Signalling Laboratory, Oncogenic Signaling and Growth Control Program, 5Gene Regulation Laboratory, Cancer Therapeutics Program, 6Molecular Imaging and Targeted Therapeutics Laboratory, Cancer Therapeutics Program, 7Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne; 8Sir Peter MacCallum Department of Oncology, Departments of 9Biochemistry and Molecular Biology, and 10Pathology, University of Melbourne, Parkville; 11Metabolic Remodelling Laboratory, Metabolic Research Unit, School of Medicine, Deakin University, Waurn Ponds; 12Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria; 13Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; 14Department of Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital; 15Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; 16Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; and 17Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California. · Pubmed 24469106
2013
  • Authors' Affiliations: Sir Peter MacCallum Department of Oncology and Departments of Pathology and Biochemistry and Molecular Biology, University of Melbourne, Parkville; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Fitzroy; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program; Translational Research Laboratory, Cancer Therapeutics Program; and Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 24089445
Miscellaneous institutions in Melbourne
2017
  • Professor of Surgery and Cancer Biology, Department of Surgical Oncology; Medical Director, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX. · Conjoint Medical Director, Melanoma Institute Australia; Clinical Professor, The University of Sydney, Sydney, New South Wales, Australia. · Senior Staff Pathologist, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Chair, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL. · Conjoint Medical Director and Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia. · Professor of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Pathology, Dermatology, and Translational Molecular Pathology; Director, Melanoma Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Co-Director, Melanoma Program; Head, Surgical Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA. · Professor of Medicine, Dermatology, and Translational Science, The University of Pittsburgh School of Medicine, Pittsburgh, PA. · Executive Director, Victorian Comprehensive Cancer Center, Melbourne, Victoria, Australia. · Manager, Clinical Data Management Systems, The University of Texas MD Anderson Cancer Center, Houston, TX. · Director General, Gustave Roussy Cancer Institute, Villejuif, France. · Director, Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center, Boston, MA. · Professor of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Melanoma and Surgical Oncology, Melanoma Institute Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 29028110
2016
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Molecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program, East Melbourne, Australia. · Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Australia. · Research Division, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, VIC, 8006, Australia. · Pubmed 27106898
2015
  • Ludwig Institute for Cancer Research (Melbourne-Austin Branch), 147-163 Studley Road, Heidelberg, VIC, 3084, Australia, · Pubmed 25662405
St. Vincent's Hospital Melbourne
2016
  • Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia; Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Australia; Department of Pathology, University of Melbourne, Australia; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Australia. Electronic address: · Pubmed 26924126
2014
  • Bioinformatics, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia. · Bioinformatics, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia; YourGene Biosciences Australia, Southbank, VIC, Australia. · Molecular Pathology Research and Development Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Victorian Melanoma Service, Alfred Hospital, Prahran, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Clayton, VIC, Australia; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sarcoma Genetics and Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Bioinformatics and Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Department of Mechanical Engineering, The University of Melbourne, Parkville, VIC, Australia. · Molecular Pathology Research and Development Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Translational Genomics & Epigenomics Laboratory, Ludwig Institute for Cancer Research, Heidelberg, VIC, Australia. · Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Bioinformatics division, The Walter and Eliza Hall Institute for Medical Research, Parkville, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Bioinformatics and Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Medicine, St. Vincent's Hospital, Fitzroy, VIC, Australia; Department of Pathology, University of Melbourne, Parkville, VIC, Australia. · Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Pathology, University of Melbourne, Parkville, VIC, Australia. · Pubmed 24752294
2015
  • aDepartment of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne bDepartment of Pathology, University of Melbourne, Parkville cDepartment of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy dMolecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program eTranslational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25588041
2014
  • 1Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, 2Translational Research Laboratory, Cancer Therapeutics Program, 3Bioinformatics Core Facility, 4The Cancer Signalling Laboratory, Oncogenic Signaling and Growth Control Program, 5Gene Regulation Laboratory, Cancer Therapeutics Program, 6Molecular Imaging and Targeted Therapeutics Laboratory, Cancer Therapeutics Program, 7Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne; 8Sir Peter MacCallum Department of Oncology, Departments of 9Biochemistry and Molecular Biology, and 10Pathology, University of Melbourne, Parkville; 11Metabolic Remodelling Laboratory, Metabolic Research Unit, School of Medicine, Deakin University, Waurn Ponds; 12Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria; 13Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; 14Department of Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital; 15Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; 16Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; and 17Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California. · Pubmed 24469106
2013
  • Authors' Affiliations: Sir Peter MacCallum Department of Oncology and Departments of Pathology and Biochemistry and Molecular Biology, University of Melbourne, Parkville; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Fitzroy; Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program; Translational Research Laboratory, Cancer Therapeutics Program; and Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 24089445
69 Other Locations Show
Yearly article counts 11616151610637322
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.